Incidence of idiopathic cardiomyopathy in patients with type 2 diabetes in Taiwan: age, sex, and urbanization status-stratified analysis

Table 2 Characteristics of the study subjects

Variables ^a	Control group		Diabetic group		p value
Variables ^a	n	%	n	%	p value
General characteristics
Age
< 45	85,872	18.11	85,872	18.11	1.0000
45–64	268,869	56.69	268,869	56.69
> 64	119,525	25.20	119,527	25.20
Mean age (± SD)	55.84	13.20	55.84	13.20	0.9912
Sex
Male	267,161	56.33	267,163	56.33	0.9986
Female	207,105	43.67	207,105	43.67
Urbanization status
Urban area	342,117	72.14	332,301	70.07	< 0.0001
Rural area	132,144	27.86	141,963	29.93
Follow-up period (year) (± SD)	9.15	1.36	8.91	1.68	< 0.0001
Comorbidities
Ischemic heart disease	55,224	11.64	104,857	22.11	< 0.0001
Hypertensive disease	141,639	29.86	267,425	56.39	< 0.0001
Rheumatic heart disease	4413	0.93	5466	1.15	< 0.0001
Valvular heart disease	17,717	3.74	18,464	3.89	< 0.0001
Congenital heart disease	1398	0.29	1901	0.40	< 0.0001
Acute myocarditis	62	0.01	114	0.02	< 0.0001
Stroke	54,290	11.45	108,520	22.88	< 0.0001
Obesity	3432	0.72	14,139	2.98	< 0.0001
Hyperlipidemia	133,807	28.21	351,046	74.02	< 0.0001
Antihypertensive medication
β-Blockers	54,974	11.59	112,678	23.76	< 0.0001
ACEi	29,942	6.31	122,133	25.75	< 0.0001
ARB	69,393	14.63	199,158	41.99	< 0.0001
Total	474,266	100.00	474,268	100.00

ACEi angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers
^aInconsistency between total population and population summed for individual variable was due to missing information

ISSN: 1475-2840